We compared the ability of these four fibrotic markers with that of the Fuc-Hpt and Mac-2 bp levels to evaluate moderate fibrosis (F ≥ 2), advanced fibrosis (F ≥ 3) and cirrhosis (F4). The gene discussed is MRS2; the disease is fibrosis.